Clinical trials
Recruiting Ischemic Stroke trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
527 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 10 |
| 2020 | 12 |
| 2021 | 27 |
| 2022 | 39 |
| 2023 | 51 |
| 2024 | 119 |
| 2025 | 139 |
| 2026 | 106 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 527 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Tiantan Hospital | 17 |
| General Hospital of Shenyang Military Region | 16 |
| Capital Medical University | 15 |
| Xuanwu Hospital, Beijing | 15 |
| Kafrelsheikh University | 13 |
| Chinese University of Hong Kong | 7 |
| Insel Gruppe AG, University Hospital Bern | 7 |
| First Affiliated Hospital of Wannan Medical College | 5 |
| Johns Hopkins University | 5 |
| The First Affiliated Hospital of University of Science and Technology of China | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Stroke | 527 |
| Stroke | 151 |
| Hemorrhagic Stroke | 40 |
| Atrial Fibrillation | 32 |
| Ischemic Attack, Transient | 21 |
| Cerebrovascular Disorders | 18 |
| Brain Diseases | 14 |
| Foramen Ovale, Patent | 13 |
| Cerebral Hemorrhage | 12 |
| Cerebral Infarction | 10 |
Trials
Showing 76 to 100 of 527. Each trial links to its page on Pharma Observatory.
427 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.